Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Acumen Pharmaceuticals Inc (ABOS)

Acumen Pharmaceuticals Inc (ABOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Acumen Pharmaceuticals Inc 1210-1220 WASHINGTON ST. SUITE 210 Newton MA 22902 USA

www.acumenpharm.com Employees: 61 P: 617-344-4190

Sector:

Medical

Description:

Acumen Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It involved in developing a novel disease for Alzheimer. The company's product pipeline consist ACU193. Acumen Pharmaceuticals Inc. is based in CHARLOTTESVILLE, Va.

Key Statistics

Overview:

Market Capitalization, $K 119,935
Enterprise Value, $K 113,725
Shares Outstanding, K 60,573
Annual Sales, $ 0 K
Annual Net Income, $ -102,330 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -26,450 K
EBIT, $ -138,230 K
EBITDA, $ -143,070 K
60-Month Beta 0.25
% of Insider Shareholders 9.30%
% of Institutional Shareholders 71.01%
Float, K 54,940
% Float 90.70%
Short Volume Ratio 0.26

Growth:

1-Year Return -11.32%
3-Year Return -67.65%
5-Year Return 0.00%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.44 on 11/12/25
Next Earnings Date N/A
Earnings Per Share ttm -2.22
EPS Growth vs. Prev Qtr 35.29%
EPS Growth vs. Prev Year 12.00%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

ABOS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -97.41%
Return-on-Assets % -70.41%
Profit Margin % 0.00%
Debt/Equity 0.33
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.25
Book Value/Share 1.54
Interest Coverage -24.14
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar